The University of Texas MD Anderson Cancer Center
Department of Cancer Biology

My lab studies the role of metabolic reprogramming in cancer and fatty liver disease. We combine metabolomics and genetic approaches to identify metabolic pathways essential for disease progression with the aim of developing new treatment strategies.

Pub Med

MDACC Faculty

Education & Training

PhD - Weizmann Institute of Science - 1998

Programs

• Cancer Biology
• Molecular and Translational Biology

---